Loading clinical trials...
Loading clinical trials...
Investigating the Effects of Camel Milk Products on the Laboratory Markers in the Patients With Chronic Hepatitis C, Genotype 2 & 3
Conditions
Interventions
Peginterferon, Ribavirin, camel milk
Peginterferon, Ribavirin
Locations
2
Iran
Faculty of Traditional Medicine
Mashhad, Razavi Khorasan Province, Iran
Mashhad University of Medical Sciences
Mashhad, Razavi Khorasan Province, Iran
Start Date
June 1, 2014
Primary Completion Date
February 1, 2015
Completion Date
February 1, 2015
Last Updated
July 29, 2016
NCT00199719
NCT06922643
NCT03612973
NCT01866930
NCT05895448
NCT02219490
Lead Sponsor
Mashhad University of Medical Sciences
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions